September 10, 2013 | Researchers from Harvard and Dana-Farber Cancer Institute announced they are starting an implanted melanoma vaccine into human clinical trials. Coated with cytokines and melanoma-specific antigens, the vaccine is a small polymer sponge that enables these two to work in sync to recognize and attack foreign cancer cells. UT San Diego